Boston Scientific's Rotablator Anticipated To Generate $15 mil. In Q4 Sales
This article was originally published in The Gray Sheet
Executive Summary
A limited reintroduction of Boston Scientific's original Rotablator rotational atherectomy device later this month is anticipated to generate $15 mil. in sales for the firm in the fourth quarter.